DAWN FY 2023 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

DAWNDay One Biopharmaceuticals, Inc.

$2B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$383,000

Operating Income

-$206M

Net Income

-$189M

EPS (Diluted)

$-2.37

Cash Flow

Operating Cash Flow

-$147M

Free Cash Flow

-$150M

Stock-Based Comp.

$39M

Balance Sheet

Total Assets

$376M

Total Liabilities

$30M

Stockholders' Equity

$347M

Cash & Equivalents

$231M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$383,000	-$531,000	+27.9%
Operating Income	-$206M	-$147M	-40.3%
Net Income	-$189M	-$142M	-32.9%